Porayko MK - Search Results

1

Bone disease in liver transplant recipients: incidence, timing, and risk factors.

Porayko MK, Wiesner RH, Hay JE, Krom RA, Dickson ER, Beaver S, Schwerman L. Porayko MK, et al. Transplant Proc. 1991 Feb;23(1 Pt 2):1462-5. Transplant Proc. 1991. PMID: 1989266 No abstract available.

2

Systemic and renal hemodynamic differences between FK506 and cyclosporine in liver transplant recipients.

Textor SC, Wiesner R, Wilson DJ, Porayko M, Romero JC, Burnett JC Jr, Gores G, Hay E, Dickson ER, Krom RA. Textor SC, et al. Transplantation. 1993 Jun;55(6):1332-9. doi: 10.1097/00007890-199306000-00023. Transplantation. 1993. PMID: 7685934 Clinical Trial.

3

Role of steroid dose in hypertension early after liver transplantation with tacrolimus (FK506) and cyclosporine.

Taler SJ, Textor SC, Canzanello VJ, Schwartz L, Porayko M, Wiesner RH, Krom RA. Taler SJ, et al. Transplantation. 1996 Dec 15;62(11):1588-92. doi: 10.1097/00007890-199612150-00011. Transplantation. 1996. PMID: 8970613

4

Selection and timing of liver transplantation in primary biliary cirrhosis and primary sclerosing cholangitis.

Wiesner RH, Porayko MK, Dickson ER, Gores GJ, LaRusso NF, Hay JE, Wahlstrom HE, Krom RA. Wiesner RH, et al. Among authors: porayko mk. Hepatology. 1992 Nov;16(5):1290-9. Hepatology. 1992. PMID: 1427667 Review.

5

Rates of vertebral bone loss before and after liver transplantation in women with primary biliary cirrhosis.

Eastell R, Dickson ER, Hodgson SF, Wiesner RH, Porayko MK, Wahner HW, Cedel SL, Riggs BL, Krom RA. Eastell R, et al. Among authors: porayko mk. Hepatology. 1991 Aug;14(2):296-300. Hepatology. 1991. PMID: 1860685

6

Complications of liver biopsy in liver transplant patients: increased sepsis associated with choledochojejunostomy.

Bubak ME, Porayko MK, Krom RA, Wiesner RH. Bubak ME, et al. Among authors: porayko mk. Hepatology. 1991 Dec;14(6):1063-5. Hepatology. 1991. PMID: 1959854

7

Long-term outcome after liver transplantation.

Eid A, Steffen R, Sterioff S, Porayko MK, Gross JB Jr, Wiesner RH, Krom RA. Eid A, et al. Among authors: porayko mk. Transplant Proc. 1989 Feb;21(1 Pt 2):2409-10. Transplant Proc. 1989. PMID: 2652786 No abstract available.

8

Comparing nephrotoxicity of FK 506 and cyclosporine regimens after liver transplantation: preliminary results from US Multicenter trial. U.S. Multicenter Liver Study Group.

Porayko MK, Gonwa TA, Klintmalm GB, Wiesner RH. Porayko MK, et al. Transplant Proc. 1995 Feb;27(1):1114-6. Transplant Proc. 1995. PMID: 7533358 Clinical Trial. No abstract available.

9

Nephrotoxicity of FK 506 and cyclosporine when used as primary immunosuppression in liver transplant recipients.

Porayko MK, Textor SC, Krom RA, Hay JE, Gores GJ, Wahlstrom HE, Sanchez-Urdazpal L, Richards T, Crotty P, Beaver S, et al. Porayko MK, et al. Transplant Proc. 1993 Feb;25(1 Pt 1):665-8. Transplant Proc. 1993. PMID: 7679835 Clinical Trial. No abstract available.

10

Early cellular rejection treated with high-dose intravenous corticosteroid therapy is associated with a decrease in the incidence of steroid-resistant rejection and graft failure from rejection.

Wiesner RH, Porayko MK, Wahlstrom HE, Gores GJ, Kamath PS, Hay JE, Krom RA. Wiesner RH, et al. Among authors: porayko mk. Transplant Proc. 1993 Apr;25(2):1791-3. Transplant Proc. 1993. PMID: 7682352 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

86 results

Search Page

Filters